Agilent Technologies Cash on Hand 2010-2025 | A
Agilent Technologies cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Agilent Technologies cash on hand for the quarter ending April 30, 2025 was $1.486B, a 11.07% decline year-over-year.
- Agilent Technologies cash on hand for 2024 was $1.329B, a 16.42% decline from 2023.
- Agilent Technologies cash on hand for 2023 was $1.59B, a 51% increase from 2022.
- Agilent Technologies cash on hand for 2022 was $1.053B, a 33.14% decline from 2021.
| Agilent Technologies Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $1,329 |
| 2023 | $1,590 |
| 2022 | $1,053 |
| 2021 | $1,575 |
| 2020 | $1,441 |
| 2019 | $1,382 |
| 2018 | $2,247 |
| 2017 | $2,678 |
| 2016 | $2,289 |
| 2015 | $2,245 |
| 2014 | $2,218 |
| 2013 | $2,675 |
| 2012 | $2,351 |
| 2011 | $3,527 |
| 2010 | $4,199 |
| 2009 | $2,493 |
| Agilent Technologies Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-04-30 | $1,486 |
| 2025-01-31 | $1,467 |
| 2024-10-31 | $1,329 |
| 2024-07-31 | $1,779 |
| 2024-04-30 | $1,671 |
| 2024-01-31 | $1,748 |
| 2023-10-31 | $1,590 |
| 2023-07-31 | $1,329 |
| 2023-04-30 | $1,175 |
| 2023-01-31 | $1,250 |
| 2022-10-31 | $1,053 |
| 2022-07-31 | $1,077 |
| 2022-04-30 | $1,207 |
| 2022-01-31 | $1,158 |
| 2021-10-31 | $1,575 |
| 2021-07-31 | $1,428 |
| 2021-04-30 | $1,380 |
| 2021-01-31 | $1,329 |
| 2020-10-31 | $1,441 |
| 2020-07-31 | $1,358 |
| 2020-04-30 | $1,324 |
| 2020-01-31 | $1,226 |
| 2019-10-31 | $1,382 |
| 2019-07-31 | $1,765 |
| 2019-04-30 | $2,155 |
| 2019-01-31 | $2,057 |
| 2018-10-31 | $2,247 |
| 2018-07-31 | $2,131 |
| 2018-04-30 | $3,011 |
| 2018-01-31 | $2,887 |
| 2017-10-31 | $2,678 |
| 2017-07-31 | $2,563 |
| 2017-04-30 | $2,389 |
| 2017-01-31 | $2,241 |
| 2016-10-31 | $2,289 |
| 2016-07-31 | $2,199 |
| 2016-04-30 | $2,139 |
| 2016-01-31 | $1,931 |
| 2015-10-31 | $2,245 |
| 2015-07-31 | $2,075 |
| 2015-04-30 | $2,197 |
| 2015-01-31 | $2,118 |
| 2014-10-31 | $2,218 |
| 2014-07-31 | $2,391 |
| 2014-04-30 | $2,950 |
| 2014-01-31 | $2,742 |
| 2013-10-31 | $2,675 |
| 2013-07-31 | $2,330 |
| 2013-04-30 | $2,519 |
| 2013-01-31 | $2,450 |
| 2012-10-31 | $2,351 |
| 2012-07-31 | $1,923 |
| 2012-04-30 | $3,896 |
| 2012-01-31 | $3,662 |
| 2011-10-31 | $3,527 |
| 2011-07-31 | $3,101 |
| 2011-04-30 | $2,975 |
| 2011-01-31 | $2,655 |
| 2010-10-31 | $4,199 |
| 2010-07-31 | $3,868 |
| 2010-04-30 | $4,209 |
| 2010-01-31 | $4,046 |
| 2009-10-31 | $2,493 |
| 2009-07-31 | $1,499 |
| 2009-04-30 | $1,412 |
| 2009-01-31 | $1,380 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $34.551B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.767B | 27.06 |
| Boston Scientific (BSX) | United States | $157.318B | 37.52 |
| Stryker (SYK) | United States | $150.713B | 30.68 |
| EssilorLuxottica (ESLOY) | France | $147.808B | 0.00 |
| Medtronic (MDT) | Ireland | $118.836B | 16.76 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.610B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.040B | 25.18 |
| ResMed (RMD) | United States | $43.006B | 30.76 |
| GE HealthCare Technologies (GEHC) | United States | $34.343B | 16.14 |
| Terumo (TRUMY) | Japan | $27.701B | 32.83 |
| Koninklijke Philips (PHG) | Netherlands | $27.289B | 18.05 |
| Insulet (PODD) | United States | $23.284B | 78.01 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.337B | 13.58 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.420B | 0.00 |
| Baxter (BAX) | United States | $12.604B | 9.74 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.222B | 30.20 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.958B | 10.70 |
| Envista Holdings (NVST) | United States | $3.609B | 25.26 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.369B | 8.42 |
| Prestige Consumer Healthcare (PBH) | United States | $3.283B | 14.57 |
| ICU Medical (ICUI) | United States | $3.164B | 21.54 |
| Haemonetics (HAE) | United States | $2.716B | 12.12 |
| LeMaitre Vascular (LMAT) | United States | $2.271B | 48.70 |
| Acuren (TIC) | United States | $2.108B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.894B | 11.92 |
| Curaleaf Holdings (CURLF) | Canada | $1.891B | 0.00 |
| AtriCure (ATRC) | United States | $1.872B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.757B | 75.46 |
| Phibro Animal Health (PAHC) | United States | $1.316B | 16.82 |
| AdaptHealth (AHCO) | United States | $1.300B | 18.48 |
| Tilray Brands (TLRY) | Canada | $1.266B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.241B | 2591.00 |
| Neogen (NEOG) | United States | $1.225B | 19.45 |
| Valneva SE (VALN) | France | $0.990B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.954B | 0.00 |
| InMode (INMD) | Israel | $0.936B | 8.66 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.626B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.607B | 0.00 |
| SNDL (SNDL) | Canada | $0.591B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.561B | 0.00 |
| ZimVie (ZIMV) | United States | $0.534B | 20.60 |
| Surmodics (SRDX) | United States | $0.532B | 0.00 |
| Evolus (EOLS) | United States | $0.497B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.482B | 16.60 |
| CeriBell (CBLL) | United States | $0.442B | 0.00 |
| Owens & Minor (OMI) | United States | $0.390B | 3.46 |
| Sanuwave Health (SNWV) | United States | $0.386B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.325B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.306B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.305B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.302B | 0.00 |
| Omeros (OMER) | United States | $0.299B | 0.00 |
| High Tide (HITI) | Canada | $0.290B | 0.00 |
| Brainsway (BWAY) | Israel | $0.287B | 58.46 |
| Viemed Healthcare (VMD) | United States | $0.284B | 21.50 |
| Aurora Cannabis (ACB) | Canada | $0.282B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.252B | 0.00 |
| Cerus (CERS) | United States | $0.243B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.241B | 0.00 |
| Quanterix (QTRX) | United States | $0.224B | 0.00 |
| Exagen (XGN) | United States | $0.222B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.219B | 0.00 |
| Organigram Global (OGI) | Canada | $0.214B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.195B | 16.30 |
| FitLife Brands (FTLF) | United States | $0.160B | 0.00 |
| Biote (BTMD) | United States | $0.159B | 5.28 |
| Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
| Jin Medical (ZJYL) | China | $0.113B | 0.00 |
| MacroGenics (MGNX) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.095B | 12.19 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Apyx Medical (APYX) | United States | $0.079B | 0.00 |
| Safety Shot (SHOT) | United States | $0.070B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 32.07 |
| Veru (VERU) | United States | $0.053B | 0.00 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 34.83 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.95 |
| Trinity Biotech (TRIB) | Ireland | $0.028B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Sharps Technology (STSS) | United States | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |